微卫星不稳定见于部分滤泡性甲状腺癌
该研究纳入485例甲状腺癌患者,涵盖所有主要组织学亚型,采用PCR、免疫组化和二代测序检测MSI/MMR缺陷。共发现4例MSI-high且MMR蛋白表达缺失的肿瘤,均来自滤泡性甲状腺癌(FTC)患者,估计FTC中MSI总体患病率为2.5%,其他亚型中MSI缺失或罕见。
要点
- 滤泡性甲状腺癌中MSI总体患病率估计为2.5%。
- MSI-high肿瘤均见于FTC,其他甲状腺癌亚型中MSI缺失或罕见。
- 对FTC进行MSI检测具有重要性。
核心结论
- 基于数据估计FTC中MSI总体患病率为2.5%,其他甲状腺癌组织学亚型中MSI要么完全缺失要么罕见。
- 这些发现强调了对FTC进行MSI检测的重要性。
研究设计与样本
- 共筛查485例甲状腺癌患者,包括195例乳头状甲状腺癌、156例滤泡性甲状腺癌、50例未分化甲状腺癌、65例髓样甲状腺癌和17例低分化甲状腺癌。
- 采用基于聚合酶链反应的检测、免疫组化和二代测序相结合的方法检测MSI/MMR缺陷。
主要发现
- 共4例肿瘤为MSI-high且伴有MMR蛋白表达缺失,均来自FTC患者。
- 对2例MSI-high FTC进行全外显子测序,其中1例肿瘤发现MSH2半合子功能缺失突变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inactivation of DNA mismatch repair (MMR) and the resulting microsatellite instability (MSI) are frequently observed in endometrial, stomach, and colorectal cancers, as well as more rarely in other solid tumor types. The prevalence of MSI in thyroid cancer has not been explored in depth, although recent studies utilizing data from large cancer sequencing efforts such as The Cancer Genome Atlas indicate that MSI is absent or at least very rare in the most common and most well studied histologic subtype, papillary thyroid carcinoma. This study aimed to determine the prevalence of MSI in thyroid cancer by using a large series comprising all major histological subtypes. METHODS: A total of 485 thyroid cancer patients were screened for MSI/MMR deficiency, including all major histologic subtypes (195 papillary thyroid carcinoma, 156 follicular thyroid carcinoma [FTC], 50 anaplastic thyroid carcinoma, 65 medullary thyroid carcinoma, and 17 poorly differentiated thyroid carcinomas) by using a combination of polymerase chain reaction-based detection, immunohistochemistry, and next-generation sequencing. RESULTS: A total of four tumors were MSI-high and had loss of MMR protein expression, all of which were from FTC patients. Whole-exome sequencing was performed on two MSI-high FTCs and revealed a hemizygous loss of function mutation in MSH2 in one tumor. CONCLUSIONS: Based on these data, it is estimated that the overall prevalence of MSI in FTC is 2.5%, and MSI is either entirely absent or rare in other histology subtypes of thyroid carcinoma. These findings highlight the importance of testing for MSI in FTC.
引用
- Genutis LK, Tomsic J, Bundschuh RA, et al. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers. Thyroid. 2019. PMID: 30747051. doi:10.1089/thy.2018.0655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。